EDMOND PHARMA (Italy) holds 9 active US FDA Type II Drug Master Files and 2 inactive, has DMF or CEP filings on record for 14 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “EDMOND PHARMA: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/edmond-pharma

Overview

EDMOND PHARMA is an active pharmaceutical ingredient (API) supplier with 10 active FDA Type II Drug Master Files, covering CHLOROPROCAINE HYDROCHLORIDE; CLENBUTEROL HYDROCHLORIDE; DEXMEDETOMIDINE HCL; ISOPROTERENOL HYDROCHLORIDE; LEVOBUPIVACAINE HYDROCHLORIDE; LURASIDONE HYDROCHLORIDE.

Core services & business areas

API ManufacturingPharmaceutical Manufacturing

Active ingredients with DMF or CEP filings

Substances for which EDMOND PHARMA holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

EDMOND PHARMA holds 9 active (11 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • CLENBUTEROL HYDROCHLORIDEActive2024-12-09
  • LEVOBUPIVACAINE HYDROCHLORIDEActive2023-09-26
  • CHLOROPROCAINE HYDROCHLORIDEActive2021-04-21
  • ROPIVACAINE HYDROCHLORIDE MONOHYDRATEActive2020-12-21
  • NORADRENALINE BITARTRATE MONOHYDRATEActive2019-07-31
  • ISOPROTERENOL HYDROCHLORIDEActive2017-05-15
  • LURASIDONE HYDROCHLORIDEActive2014-09-30
  • DEXMEDETOMIDINE HCLActive2013-03-12
  • MIDODRINE HYDROCHLORIDEActive2002-06-21
  • TULOBUTEROL BASEInactive2008-06-27
  • CARTEOLOL HYDROCHLORIDEInactive1997-10-23

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to EDMOND PHARMA, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to EDMOND PHARMA in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this EDMOND PHARMA?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.